Weight | 1 lbs |
---|---|
Dimensions | 9 × 5 × 2 in |
express system | HEK293 |
product tag | C-His-Avi |
purity | > 95% as determined by Tris-Bis PAGE;> 93% as determined by HPLC |
background | BTN3A2/BT3.2 butyrophilin mRNA expression by tumoral cells was previously identified as a prognostic factor in a small cohort of high grade serous epithelial ovarian cancer (HG-EOC).In conclusion, BT3.2 protein is a potential prognostic biomarker for the identification of HG-EOC patients with better outcome. In contrast, high CD206 /CD68 expression is associated with high risk of disease progression. |
molecular weight | The protein has a predicted MW of 26.5 kDa. Due to glycosylation, the protein migrates to 30-38 kDa based on Tris-Bis PAGE result. |
available size | 100 µg, 500 µg |
endotoxin | Less than 1EU per μg by the LAL method. |
Biotinylated Human BTN3A2 Protein 3129
$525.00 – $1,750.00
Summary
- Expression: HEK293
- Pure: Yes (HPLC)
- Amino Acid Range: Gln30-Trp248
Biotinylated Human BTN3A2 Protein 3129
protein |
---|
Size and concentration 100, 500µg and lyophilized |
Form Lyophilized |
Storage Instructions Valid for 12 months from date of receipt when stored at -80°C. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
Storage buffer Shipped at ambient temperature. |
Purity > 95% as determined by Tris-Bis PAGE |
target relevance |
---|
BTN3A2/BT3.2 butyrophilin mRNA expression by tumoral cells was previously identified as a prognostic factor in a small cohort of high grade serous epithelial ovarian cancer (HG-EOC).In conclusion, BT3.2 protein is a potential prognostic biomarker for the identification of HG-EOC patients with better outcome. In contrast, high CD206 /CD68 expression is associated with high risk of disease progression. |
Protein names Butyrophilin subfamily 3 member A2 |
Gene names BTN3A2,BTN3A2 BT3.2 BTF3 BTF4 |
Protein family Immunoglobulin superfamily, BTN/MOG family |
Mass 9606Da |
Function Plays a role in T-cell responses in the adaptive immune response. Inhibits the release of IFNG from activated T-cells. |
Subellular location Cell membrane ; Single-pass type I membrane protein . |
Tissues Detected in T-cells and natural killer cells. |
Structure Homodimer. |
Post-translational modification N-glycosylated. |
Target Relevance information above includes information from UniProt accession: P78410 |
The UniProt Consortium |
![]() |
The purity of Biotinylated Human BTN3A2 is greater than 93% as determined by SEC-HPLC. |
![]() |
Biotinylated Human BTN3A2 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%. |
Publications
pmid | title | authors | citation |
---|---|---|---|
We haven't added any publications to our database yet. |
relevant to this product |
---|
# | ||
---|---|---|
Please enter your product and batch number here to retrieve product datasheet, SDS, and QC information. |
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.